Tag: Hepatitis D

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Hepatitis D

Gilead to Acquire German Biotech MYR for $1.39 Billion

Added to Collection on: 2020-12-10 15:00:00

Tags for this article:

Medical specialties
Clinical medicine
Infectious causes of cancer
Medicine
Specialty drugs
Healthcare-associated infections
Viral diseases
Gilead Sciences
Hepatitis D
Viral hepatitis
Hepatitis
Liver disease
MYR GmbH

Click the tags to see associated articles and topics

View Article Details
Hepatitis Drugs Market to Witness Rise in Revenues during the forecast Period 2020 – 2026: F ...

Added to Collection on: 2021-02-19 06:56:15

Tags for this article:

Health sciences
Life Sciences
Health care
Specialty drugs
Gilead Sciences
Pharmaceutical industry
Novartis
Bristol-Myers Squibb
Hepatitis D
Hoffmann-La Roche
AbbVie
GlaxoSmithKline

Click the tags to see associated articles and topics

View Article Details
VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV ...

Added to Collection on: 2021-02-24 13:52:30

Tags for this article:

Medical specialties
Branches of biology
Clinical medicine
Virology
Viral structural proteins
Virus-like particle
Hepadnaviridae
Vaccine
Virus
Myristoylation
Hepatitis D
Hepatitis B
VLP BioTech Inc.
Gilead Sciences

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and ...

Added to Collection on: 2021-03-09 21:00:00

Tags for this article:

Organic compounds
Chemical compounds
Branches of biology
Breakthrough therapy
Chloroarenes
Lonafarnib
Organobromides
Piperidines
Ureas
Progeria
Hepatitis D
Laminopathy
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals to Host Conference Call for First Quarter 2021 Financial Results and ...

Added to Collection on: 2021-04-29 04:52:30

Tags for this article:

Life Sciences
Health sciences
Health
Senescence
Diabetes
Laminopathy
Muscular dystrophy
Lonafarnib
Progeria
Hepatitis D
Peginterferon-alfa
Biopharmaceutical
eiger biopharmaceuticals inc

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals Announces Peginterferon Lambda to be Added to Multi-Center Phase 3 ...

Added to Collection on: 2021-05-03 12:00:00

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Antiviral drugs
Cytokines
Interferon
Hepatitis D
COVID-19
Lambdavirus
Viral hepatitis
Sjögren syndrome
Cytokine storm
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Eiger Biopharmaceuticals (EIGR) Stock is Higher After Inclusion in COVID-19 Study

Added to Collection on: 2021-05-03 18:11:15

Tags for this article:

Branches of biology
Organic compounds
Chemical compounds
Chloroarenes
Breakthrough therapy
Lonafarnib
Organobromides
Piperidines
Ureas
Laminopathy
Hepatitis D
Prenylation
Lambda
eiger biopharmaceuticals inc
ECPI Global Ethical Equity TR

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business ...

Added to Collection on: 2021-05-06 19:52:30

Tags for this article:

Health sciences
Health
Organic compounds
Clinical research
Pharmaceutical industry
Drug discovery
Orphan drugs
Design of experiments
Lonafarnib
Hepatitis D
HDV
Progeria
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Hepatitis B Treatment Market To See Huge Growth By 2026 | Apotex, Arbutus Biopharma, Bristol ...

Added to Collection on: 2021-05-08 08:15:00

Tags for this article:

Medical specialties
Health
Infectious causes of cancer
Healthcare-associated infections
Vaccine-preventable diseases
Viral diseases
Hepatitis
Arbutus Biopharma
Pharmaceutical industry in China
Apotex
Hepatitis D
World Hepatitis Day

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Added to Collection on: 2021-07-02 20:03:45

Tags for this article:

Branches of biology
Organic compounds
Chemical compounds
Inheritance
Labour law
Property law
Vesting
Laminopathy
Progeria
Eiger
Hepatitis D
Lonafarnib
eiger biopharmaceuticals inc

Click the tags to see associated articles and topics

View Article Details
Book a Demo